These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
706 related items for PubMed ID: 26059477
1. Structural and dynamical aspects of Streptococcus gordonii FabH through molecular docking and MD simulations. Shamim A, Abbasi SW, Azam SS. J Mol Graph Model; 2015 Jul; 60():180-96. PubMed ID: 26059477 [Abstract] [Full Text] [Related]
2. Homology modeling and docking studies of FabH (β-ketoacyl-ACP synthase III) enzyme involved in type II fatty acid biosynthesis of Chlorella variabilis: a potential algal feedstock for biofuel production. Misra N, Patra MC, Panda PK, Sukla LB, Mishra BK. J Biomol Struct Dyn; 2013 Mar; 31(3):241-57. PubMed ID: 22830394 [Abstract] [Full Text] [Related]
3. Novel FabH inhibitors: an updated article literature review (July 2012 to June 2013). Song H, Ao GZ, Li HQ. Expert Opin Ther Pat; 2014 Jan; 24(1):19-27. PubMed ID: 24083428 [Abstract] [Full Text] [Related]
4. PqsBC, a Condensing Enzyme in the Biosynthesis of the Pseudomonas aeruginosa Quinolone Signal: CRYSTAL STRUCTURE, INHIBITION, AND REACTION MECHANISM. Drees SL, Li C, Prasetya F, Saleem M, Dreveny I, Williams P, Hennecke U, Emsley J, Fetzner S. J Biol Chem; 2016 Mar 25; 291(13):6610-24. PubMed ID: 26811339 [Abstract] [Full Text] [Related]
5. Refined structures of beta-ketoacyl-acyl carrier protein synthase III. Qiu X, Janson CA, Smith WW, Head M, Lonsdale J, Konstantinidis AK. J Mol Biol; 2001 Mar 16; 307(1):341-56. PubMed ID: 11243824 [Abstract] [Full Text] [Related]
6. A combined approach of docking and 3D QSAR study of beta-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors. Ashek A, Cho SJ. Bioorg Med Chem; 2006 Mar 01; 14(5):1474-82. PubMed ID: 16275103 [Abstract] [Full Text] [Related]
7. Novel Schiff-base-derived FabH inhibitors with dioxygenated rings as antibiotic agents. Zhou Y, Du QR, Sun J, Li JR, Fang F, Li DD, Qian Y, Gong HB, Zhao J, Zhu HL. ChemMedChem; 2013 Mar 01; 8(3):433-41. PubMed ID: 23401291 [Abstract] [Full Text] [Related]
8. Crystal structure of a substrate complex of Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III (FabH) with lauroyl-coenzyme A. Musayev F, Sachdeva S, Scarsdale JN, Reynolds KA, Wright HT. J Mol Biol; 2005 Mar 11; 346(5):1313-21. PubMed ID: 15713483 [Abstract] [Full Text] [Related]
9. Design of Arylsulfonylhydrazones as Potential FabH Inhibitors: Synthesis, Antimicrobial Evaluation and Molecular Docking. Fernandes TB, Segretti ND, Lourenço FR, Cândido TM, Baby AR, Barbosa EG, Parise-Filho R. Med Chem; 2021 Mar 11; 17(5):474-484. PubMed ID: 31763975 [Abstract] [Full Text] [Related]
10. Structural Characterisation of the Beta-Ketoacyl-Acyl Carrier Protein Synthases, FabF and FabH, of Yersinia pestis. Nanson JD, Himiari Z, Swarbrick CM, Forwood JK. Sci Rep; 2015 Oct 15; 5():14797. PubMed ID: 26469877 [Abstract] [Full Text] [Related]
11. Identification, substrate specificity, and inhibition of the Streptococcus pneumoniae beta-ketoacyl-acyl carrier protein synthase III (FabH). Khandekar SS, Gentry DR, Van Aller GS, Warren P, Xiang H, Silverman C, Doyle ML, Chambers PA, Konstantinidis AK, Brandt M, Daines RA, Lonsdale JT. J Biol Chem; 2001 Aug 10; 276(32):30024-30. PubMed ID: 11375394 [Abstract] [Full Text] [Related]
12. Discovery of vinylogous carbamates as a novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors. Li HQ, Luo Y, Zhu HL. Bioorg Med Chem; 2011 Aug 01; 19(15):4454-9. PubMed ID: 21742506 [Abstract] [Full Text] [Related]
13. Crystal structure and substrate specificity of the beta-ketoacyl-acyl carrier protein synthase III (FabH) from Staphylococcus aureus. Qiu X, Choudhry AE, Janson CA, Grooms M, Daines RA, Lonsdale JT, Khandekar SS. Protein Sci; 2005 Aug 01; 14(8):2087-94. PubMed ID: 15987898 [Abstract] [Full Text] [Related]
14. Design and synthesis of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III (FabH) as potential antibacterial agents. Shi L, Fang RQ, Zhu ZW, Yang Y, Cheng K, Zhong WQ, Zhu HL. Eur J Med Chem; 2010 Sep 01; 45(9):4358-64. PubMed ID: 20557983 [Abstract] [Full Text] [Related]
15. Identification of a new binding site in E. coli FabH using Molecular dynamics simulations: validation by computational alanine mutagenesis and docking studies. Ramamoorthy D, Turos E, Guida WC. J Chem Inf Model; 2013 May 24; 53(5):1138-56. PubMed ID: 23581389 [Abstract] [Full Text] [Related]
16. Structure-based design, synthesis, and study of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents. Nie Z, Perretta C, Lu J, Su Y, Margosiak S, Gajiwala KS, Cortez J, Nikulin V, Yager KM, Appelt K, Chu S. J Med Chem; 2005 Mar 10; 48(5):1596-609. PubMed ID: 15743201 [Abstract] [Full Text] [Related]
17. Identification and analysis of the acyl carrier protein (ACP) docking site on beta-ketoacyl-ACP synthase III. Zhang YM, Rao MS, Heath RJ, Price AC, Olson AJ, Rock CO, White SW. J Biol Chem; 2001 Mar 16; 276(11):8231-8. PubMed ID: 11078736 [Abstract] [Full Text] [Related]
18. Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors. Lv PC, Sun J, Luo Y, Yang Y, Zhu HL. Bioorg Med Chem Lett; 2010 Aug 01; 20(15):4657-60. PubMed ID: 20594840 [Abstract] [Full Text] [Related]
19. Antibacterial FabH Inhibitors with Mode of Action Validated in Haemophilus influenzae by in Vitro Resistance Mutation Mapping. McKinney DC, Eyermann CJ, Gu RF, Hu J, Kazmirski SL, Lahiri SD, McKenzie AR, Shapiro AB, Breault G. ACS Infect Dis; 2016 Jul 08; 2(7):456-64. PubMed ID: 27626097 [Abstract] [Full Text] [Related]
20. The crystal structure of beta-ketoacyl-acyl carrier protein synthase II from Synechocystis sp. at 1.54 A resolution and its relationship to other condensing enzymes. Moche M, Dehesh K, Edwards P, Lindqvist Y. J Mol Biol; 2001 Jan 19; 305(3):491-503. PubMed ID: 11152607 [Abstract] [Full Text] [Related] Page: [Next] [New Search]